Delivery Order SPE2DB24D1021-SPE2DB25FFBDD
Award Date 9/24/25
Potential Completion Date 9/25/25
Potential Value $6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,597.57 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for the supply of Celebrex 200 mg capsules (100 count). This is a firm fixed-price, non-set-aside competitive contract with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Celebrex 200 mg capsules in unit dose packaging (100 count) with a contract value of $6,610.43. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and represents a non-competitive set-aside contract. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Celebrex 200 mg capsules (100 count) with a contract value of $2,387.86. This firm fixed-price delivery order, which will be completed by August 14, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- On August 13, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,526.68 to AmerisourceBergen Drug Corp for 100 capsules of Celebrex 200 mg. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $3,786.34 for 100 capsules of Celebrex 200 mg on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Celebrex is a nonsteroidal anti-inflammatory drug commonly used for pain management and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Celebrex 200 mg capsules in unit dose packaging (100 count) with a ceiling value of $3,349.86. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set to be completed by September 26, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,507.44 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Celecoxib 200 mg capsules in quantities of 500 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 11, 2025. The award was issued from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery...
- The Defense Logistics Agency awarded a $1,512.46 delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 100 mg, a nonsteroidal anti-inflammatory medication. This firm fixed-price contract, with an ultimate completion date of July 1, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was competitively awarded without...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of pharmaceutical products and medical supplies, including Celebrex 100mg, to support military treatment programs and facilities. The contract is a firm fixed price delivery order valued at $2,650.19 with a performance period through April 9, 2024. Amerisourcebergen Drug Corp also holds an...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $166,072.60 firm fixed-price delivery order contract is for the supply of Celebrex 200mg medication, a commonly prescribed drug for the treatment of pain and inflammation. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...